Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study
PMID: 39372212
Source: Front Pharmacol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL